New targeted therapy finds and eliminates deadly leukemia stem cells
Thursday, July 2, 2009 - 11:42
in Biology & Nature
New research describes a molecular tool that shows great promise as a therapeutic for human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer. The study, published by Cell Press in the July 2nd issue of the journal Cell Stem Cell, describes exciting preclinical studies in which a new therapeutic approach selectively attacks human cancer cells grown in the lab and in animal models of leukemia.
Read the whole article on Physorg
More from Physorg
Related
- New targeted therapy finds and eliminates deadly leukemia stem cellsThu, 2 Jul 2009, 12:44:52 EDT
- Leukemia stem cells have more in common with embryonic stem cells than adult stem cellsThu, 5 Feb 2009, 12:45:38 EST
- Toronto researcher's discovery points to a new treatment avenue for acute myeloid leukemiaMon, 6 Jul 2009, 11:29:24 EDT
- Inventive combination of research approaches identifies new target for treating leukemiaMon, 5 Oct 2009, 15:16:05 EDT
- Stripping leukemia-initiating cells of their 'invisibility cloak'Thu, 23 Jul 2009, 12:54:25 EDT